Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:S1-S4, 2006
DOI: 10.2337/db06-S000
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steiner, D. F.
Right arrow Articles by Ferrannini, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Steiner, D. F.
Right arrow Articles by Ferrannini, E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Editorial

Toward a Systems Biology of Insulin Secretion and Type 2 Diabetes

Donald F. Steiner1, Christian Boitard2, Erol Cerasi3, Suad Efendic4, Jean-Claude Henquin5, and Ele Ferrannini6

1 Departments of Biochemistry and Medicine, University of Chicago, Chicago, Illinois
2 Institut National de la Santé et de la Recherche Médicale U561, St. Vincent de Paul Hospital, Paris, France
3 Department of Endocrinology and Metabolism, Hebrew University Hadassah Medical Center, Jerusalem, Israel
4 Department of Molecular Medicine, Division of Endocrinology & Diabetes, Karolinska Hospital, Stockholm, Sweden
5 Unit of Endocrinology and Metabolism, University of Louvain, Brussels, Belgium
6 Metabolism Unit, CNR Institute of Clinical Physiology, University of Pisa, Pisa, Italy

Address correspondence and reprint requests to Donald F. Steiner. E-mail: dfsteine@midway.uchicago.edu

Abbreviations: CNS, central nervous system; FFA, free fatty acid; FFAR, free fatty acid receptor; GBS, gastric bypass surgery; GIP, gastric inhibitory polypeptide; GLP, glucagon-like peptide; HGP, hepatic glucose production; IL, interleukin; KATP channel, ATP-sensitive K+ channel

The first 300 words of the full text of this article appear below.

Although it is clear that ß-cell pathology, in particular disordered insulin secretion, is a key underlying pathogenetic feature of most forms of diabetes, complex interactions of the islets with other organs, such as brain, liver, gut, and several peripheral tissues, are also essential for the normal integration of metabolism. It is this area that has been explored in the Seventh Annual Servier-IGIS Meeting, which was held last Spring in St. Jean Cap Ferrat in Southern France. The focus of these meetings, since their inception in 2000, has been the ß-cell and the mechanisms underlying its development and function as the source of insulin, the most essential regulator of the blood glucose level.

The familiar pathways of glucose, lipid, and amino acid metabolism in humans and other mammals are, of course, fundamental to almost all organisms, except perhaps for the most highly specialized bacteria, so it is not surprising that insulin-like molecules and the insulin/IGF receptor signaling system are well conserved features of all metazoans that have been studied. With the rise of multicellular organisms in evolution came the need to regulate and coordinate metabolism and growth in order to maintain both the constancy of the internal environment (homeostasis) and also to respond to the external environment. One of the most prominent environmental stimuli had to be the availability of nutrients and fuels for survival and growth. The insulin-like hormones, insulin and IGF, appear to have evolved, along with a panoply of other regulatory substances, to fine-tune the efficient uptake, storage, and utilization of nutrients for either energy production or growth.

Appropriately, the symposium opened with an introductory lecture by Leopold, reviewing our current knowledge of the control of metabolism and growth in the fruit fly, Drosophila melanogaster, by insulin-like peptides and an insulin signaling pathway that is remarkably similar . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.